Key result
Strategies to promote long-term cardiac implant site health, including proper device selection, infection management, and emerging non-invasive techniques like Raman spectroscopy, are essential for improving implant survival.
Why the study?
Active implantable medical devices improve patient quality of life, making implant longevity and strategies to enhance implant life of paramount importance.
This review outlines current protocols for managing CIED infections and explores emerging technologies like Raman spectroscopy for individualized implant care.
Active implantable medical devices (AIMDs) are used for diagnostic, therapeutic, and rehabilitation purposes. Implants and devices improve the quality of life and well-being of the recipient. These include cardiac pacemakers (for controlling heart rhythm), ventricular assist devices (heart support), spinal cord stimulators (chronic pain management), deep brain stimulators (control symptoms of conditions, such as Parkinson’s disease, essential tremor, epilepsy, and depression), cochlear implants (enable hearing) and, more recently, bionic eyes (restore vision). Implant life and strategies to enhance it is of paramount importance. The use of non-invasive techniques like Raman Spectroscopy to match the implant and recipient characteristics and non-invasive diagnosis of rejection would be the way forward.
No takes yet. Share an insight, caveat, or question.
Radhakrishnan et al. (2020) conducted a review in Cardiac implantable electronic device (CIED) infections and implant site health. Cardiac implant site health promotion strategies was evaluated. Strategies to promote long-term cardiac implant site health, including proper device selection, infection management, and emerging non-invasive techniques like Raman spectroscopy, are essential for improving implant survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: